Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age
A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that...
Gespeichert in:
| Veröffentlicht in: | Reviews of infectious diseases 1983-05, Vol.5 (3), p.596-605 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 605 |
|---|---|
| container_issue | 3 |
| container_start_page | 596 |
| container_title | Reviews of infectious diseases |
| container_volume | 5 |
| creator | Ministries of Health of Brazil Ministries of Health of Chile Ministries of Health of Costa Rica Ministries of Health of Ecuador The Pan American Health Organization |
| description | A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that a success rate of 90% can be attained if initial vaccination is given at nine to 11 months of age, depending on the area. Post-vaccination titers also varied, and higher titers were generally observed in groups with higher seroconversion rates. |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_80594128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4453085</jstor_id><sourcerecordid>4453085</sourcerecordid><originalsourceid>FETCH-LOGICAL-j142t-10395f40bc799af1813b137d5a7502d5fa92bd18e2ddcf8c6d2da9ed2b7b12a43</originalsourceid><addsrcrecordid>eNo9kM1LwzAchntQ5pz-Bwo5eSskadOmxzL8GGwIbnot-fjVZbTJTFJxV_9yKxs7vS88D-_hvUimmBQ0xZwXV8l1CDuMWVbmxSSZFLysMKXT5HcN3ilnv8EH4yx6ExECElajFYjQjb220UinD2hj4iihhdWDAo3k4ax8CKWMFfF_wFi0HJtFdQ_eKGHRfGs67cGitflB0SFC0crZuA3Itaj-hJvkshVdgNtTzpL3p8fN_CVdvj4v5vUy3ZGcxpTgrGJtjqUqq0q0hJNMkqzUTJQMU81aUVGpCQeqtWq5KjTVogJNZSkJFXk2Sx6Ou3vvvgYIselNUNB1woIbQsMxq3JC-Sjen8RB9qCbvTe98IfmdNrI7458F6LzZ5znLMOcZX88K3Hc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80594128</pqid></control><display><type>article</type><title>Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Ministries of Health of Brazil ; Ministries of Health of Chile ; Ministries of Health of Costa Rica ; Ministries of Health of Ecuador ; The Pan American Health Organization</creator><creatorcontrib>Ministries of Health of Brazil ; Ministries of Health of Chile ; Ministries of Health of Costa Rica ; Ministries of Health of Ecuador ; The Pan American Health Organization</creatorcontrib><description>A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that a success rate of 90% can be attained if initial vaccination is given at nine to 11 months of age, depending on the area. Post-vaccination titers also varied, and higher titers were generally observed in groups with higher seroconversion rates.</description><identifier>ISSN: 0162-0886</identifier><identifier>PMID: 6879022</identifier><language>eng</language><publisher>United States: University of Chicago Press</publisher><subject>Age Factors ; Age groups ; Antibodies ; Antibodies, Viral - analysis ; Children ; Humans ; Immunity ; Infant ; Infants ; Infections ; Latin America ; Measles ; Measles - prevention & control ; Measles Vaccine - administration & dosage ; Measles Vaccine - adverse effects ; Measles Vaccine - immunology ; Measles vaccines ; Nutrition Disorders - diagnosis ; Population ; Residence Characteristics ; Session III: Current Measles Control ; Towns ; Vaccination ; Vaccination - methods</subject><ispartof>Reviews of infectious diseases, 1983-05, Vol.5 (3), p.596-605</ispartof><rights>Copyright 1983 The University of Chicago</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4453085$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4453085$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>315,781,785,804,58022,58255</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6879022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ministries of Health of Brazil</creatorcontrib><creatorcontrib>Ministries of Health of Chile</creatorcontrib><creatorcontrib>Ministries of Health of Costa Rica</creatorcontrib><creatorcontrib>Ministries of Health of Ecuador</creatorcontrib><creatorcontrib>The Pan American Health Organization</creatorcontrib><title>Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age</title><title>Reviews of infectious diseases</title><addtitle>Rev Infect Dis</addtitle><description>A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that a success rate of 90% can be attained if initial vaccination is given at nine to 11 months of age, depending on the area. Post-vaccination titers also varied, and higher titers were generally observed in groups with higher seroconversion rates.</description><subject>Age Factors</subject><subject>Age groups</subject><subject>Antibodies</subject><subject>Antibodies, Viral - analysis</subject><subject>Children</subject><subject>Humans</subject><subject>Immunity</subject><subject>Infant</subject><subject>Infants</subject><subject>Infections</subject><subject>Latin America</subject><subject>Measles</subject><subject>Measles - prevention & control</subject><subject>Measles Vaccine - administration & dosage</subject><subject>Measles Vaccine - adverse effects</subject><subject>Measles Vaccine - immunology</subject><subject>Measles vaccines</subject><subject>Nutrition Disorders - diagnosis</subject><subject>Population</subject><subject>Residence Characteristics</subject><subject>Session III: Current Measles Control</subject><subject>Towns</subject><subject>Vaccination</subject><subject>Vaccination - methods</subject><issn>0162-0886</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1LwzAchntQ5pz-Bwo5eSskadOmxzL8GGwIbnot-fjVZbTJTFJxV_9yKxs7vS88D-_hvUimmBQ0xZwXV8l1CDuMWVbmxSSZFLysMKXT5HcN3ilnv8EH4yx6ExECElajFYjQjb220UinD2hj4iihhdWDAo3k4ax8CKWMFfF_wFi0HJtFdQ_eKGHRfGs67cGitflB0SFC0crZuA3Itaj-hJvkshVdgNtTzpL3p8fN_CVdvj4v5vUy3ZGcxpTgrGJtjqUqq0q0hJNMkqzUTJQMU81aUVGpCQeqtWq5KjTVogJNZSkJFXk2Sx6Ou3vvvgYIselNUNB1woIbQsMxq3JC-Sjen8RB9qCbvTe98IfmdNrI7458F6LzZ5znLMOcZX88K3Hc</recordid><startdate>198305</startdate><enddate>198305</enddate><creator>Ministries of Health of Brazil</creator><creator>Ministries of Health of Chile</creator><creator>Ministries of Health of Costa Rica</creator><creator>Ministries of Health of Ecuador</creator><creator>The Pan American Health Organization</creator><general>University of Chicago Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>198305</creationdate><title>Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age</title><author>Ministries of Health of Brazil ; Ministries of Health of Chile ; Ministries of Health of Costa Rica ; Ministries of Health of Ecuador ; The Pan American Health Organization</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j142t-10395f40bc799af1813b137d5a7502d5fa92bd18e2ddcf8c6d2da9ed2b7b12a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Age Factors</topic><topic>Age groups</topic><topic>Antibodies</topic><topic>Antibodies, Viral - analysis</topic><topic>Children</topic><topic>Humans</topic><topic>Immunity</topic><topic>Infant</topic><topic>Infants</topic><topic>Infections</topic><topic>Latin America</topic><topic>Measles</topic><topic>Measles - prevention & control</topic><topic>Measles Vaccine - administration & dosage</topic><topic>Measles Vaccine - adverse effects</topic><topic>Measles Vaccine - immunology</topic><topic>Measles vaccines</topic><topic>Nutrition Disorders - diagnosis</topic><topic>Population</topic><topic>Residence Characteristics</topic><topic>Session III: Current Measles Control</topic><topic>Towns</topic><topic>Vaccination</topic><topic>Vaccination - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Ministries of Health of Brazil</creatorcontrib><creatorcontrib>Ministries of Health of Chile</creatorcontrib><creatorcontrib>Ministries of Health of Costa Rica</creatorcontrib><creatorcontrib>Ministries of Health of Ecuador</creatorcontrib><creatorcontrib>The Pan American Health Organization</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Reviews of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ministries of Health of Brazil</au><au>Ministries of Health of Chile</au><au>Ministries of Health of Costa Rica</au><au>Ministries of Health of Ecuador</au><au>The Pan American Health Organization</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age</atitle><jtitle>Reviews of infectious diseases</jtitle><addtitle>Rev Infect Dis</addtitle><date>1983-05</date><risdate>1983</risdate><volume>5</volume><issue>3</issue><spage>596</spage><epage>605</epage><pages>596-605</pages><issn>0162-0886</issn><abstract>A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that a success rate of 90% can be attained if initial vaccination is given at nine to 11 months of age, depending on the area. Post-vaccination titers also varied, and higher titers were generally observed in groups with higher seroconversion rates.</abstract><cop>United States</cop><pub>University of Chicago Press</pub><pmid>6879022</pmid><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0162-0886 |
| ispartof | Reviews of infectious diseases, 1983-05, Vol.5 (3), p.596-605 |
| issn | 0162-0886 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80594128 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing |
| subjects | Age Factors Age groups Antibodies Antibodies, Viral - analysis Children Humans Immunity Infant Infants Infections Latin America Measles Measles - prevention & control Measles Vaccine - administration & dosage Measles Vaccine - adverse effects Measles Vaccine - immunology Measles vaccines Nutrition Disorders - diagnosis Population Residence Characteristics Session III: Current Measles Control Towns Vaccination Vaccination - methods |
| title | Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of Age |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T04%3A59%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroconversion%20Rates%20and%20Measles%20Antibody%20Titers%20Induced%20by%20Measles%20Vaccination%20in%20Latin%20American%20Children%20Six%20to%2012%20Months%20of%20Age&rft.jtitle=Reviews%20of%20infectious%20diseases&rft.au=Ministries%20of%20Health%20of%20Brazil&rft.date=1983-05&rft.volume=5&rft.issue=3&rft.spage=596&rft.epage=605&rft.pages=596-605&rft.issn=0162-0886&rft_id=info:doi/&rft_dat=%3Cjstor_proqu%3E4453085%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80594128&rft_id=info:pmid/6879022&rft_jstor_id=4453085&rfr_iscdi=true |